The UC Davis Innovation and Economic Development Office has launched the Aggie Venture Accelerator, an initiative designed to support early stage startups developing solutions at the intersection of life science, food and health.
The first Aggie Square Community Benefits Partnership Agreement (CBPA) Annual Progress Report has been released by UC Davis, the City of Sacramento and Wexford Science & Technology, documenting significant progress towards meeting many of the goals outlined in the CBPA.
UC Davis Health Ventures, part of the Innovation and Economic Development Office at UC Davis, today announced the appointment of Troels Adrian as Director of Industry Engagement.
Introducing the Food & Health Angels Network, a groundbreaking initiative launched to accelerate science-driven innovations in food and health, addressing the pressing issue of metabolic disease.
UC Davis showcased groundbreaking translational research and innovative biotech startups at the 8th Annual Biotech Innovation Gallery in San Francisco. Hosted by the UC Davis Innovation and Economic Development Office, the event brought in over 330 attendees to connect with and explore potential partnerships with researchers and startup founders, aligning with the J.P. Morgan Healthcare Conference.
At Venture Catalyst, part of the UC Davis Innovation and Economic Development Office, we're proud to support the translation of UC Davis research and technology into real-world applications by fostering the development of new ventures. Through strategic collaborations, training and mentorship programs, funding translational research, and proactive outreach, we foster the university’s entrepreneurial culture and ensure that the benefits of the UC Davis innovation ecosystem extend beyond the lab.
The Discovery Forum showcased UC Davis as a leader in GLP-1 and metabolic health innovation, bringing together researchers, industry experts, and investors to explore how metabolic hormones are reshaping health and nutrition. With cutting-edge research, world-class facilities, and a strong innovation ecosystem, the event was a reminder of UC Davis’ unique ability to translate metabolic science into real-world health and wellness solutions.
UC Davis Health Ventures, part of the Innovation and Economic Development Office (IEDO) at the University of California, Davis, today announced the first investment from its Investing in the Future of Medicine (IFM) Fund, backing Delix Therapeutics.
Andrew Brown of UC Davis Health Ventures shares his thoughts on the creation and launch of the TRIage Innovation Forum—an engaging, rapid-pitch platform that helps researchers present their work in three minutes and receive tailored guidance, resources and connections to accelerate the translation of their innovations into real-world health solutions.
UC Davis saw a 34% increase in records of invention in FY 2025, driven largely by health-related innovations and first-time contributors, reflecting a growing culture of commercialization and cross-campus collaboration led by the Innovation and Economic Development Office.
UC Davis welcomed residents to Anova Aggie Square, the first student housing ever offered on the Sacramento campus. Anova Aggie Square is a smart residential complex that is now home to students from the UC Davis School of Medicine, the Betty Irene Moore School of Nursing at UC Davis and other graduate programs.
UC Davis strengthens its global life sciences ecosystem with strategic partnerships with FLANN Inc. and HM Venture Partners, aiming to attract international biotech startups to Aggie Square and accelerate the commercialization of groundbreaking healthcare innovations.
